Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Petersenn

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2008
Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantationAnja K Arbeiter, Rainer Büscher, Stephan Petersenn, et al.
European Journal of Endocrinology|January 14, 2018
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016Ann McCormack, Olaf M Dekkers, Stephan Petersenn, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2009
Somatostatin receptor expression in an epitheloid hemangioma causing oncogenic osteomalaciaKarsten Müssig, Mehmet Ozer Oksüz, Christina Pfannenberg, et al.
Clinical Chemistry|August 22, 2012
Automated 22-kD growth hormone-specific assay without interference from PegvisomantJenny Manolopoulou, Younes Alami, Stephan Petersenn, et al.
Pituitary|November 26, 2015
Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS studyPhilippe J Caron, John S Bevan, Stephan Petersenn, et al.
European Journal of Endocrinology|April 15, 2004
Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal massNicole Unger, Ingo Lopez Schmidt, Christian Pitt, et al.
European Journal of Endocrinology|December 13, 2018
MRI T2 signal intensity and tumor response in patients with GH-secreting pituitary macroadenoma: PRIMARYS post-hoc analysisFabrice Bonneville, Louis-David Rivière, Stephan Petersenn, et al.
Clinical Endocrinology|January 18, 2012
Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomasKarsten Müssig, Tobias Wehrmann, Helmut Dittmann, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 7, 2020
Bevacizumab in Aggressive Pituitary Adenomas - Experience with 3 PatientsKatharina Osterhage, Roman Rotermund, Michael Droste, et al.
European Journal of Endocrinology|October 20, 2017
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomasGerald Raverot, Pia Burman, Ann McCormack, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2008
Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantationAnja K Arbeiter, Rainer Büscher, Stephan Petersenn, et al.
European Journal of Endocrinology|January 14, 2018
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016Ann McCormack, Olaf M Dekkers, Stephan Petersenn, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2009
Somatostatin receptor expression in an epitheloid hemangioma causing oncogenic osteomalaciaKarsten Müssig, Mehmet Ozer Oksüz, Christina Pfannenberg, et al.
Clinical Chemistry|August 22, 2012
Automated 22-kD growth hormone-specific assay without interference from PegvisomantJenny Manolopoulou, Younes Alami, Stephan Petersenn, et al.
Pituitary|November 26, 2015
Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS studyPhilippe J Caron, John S Bevan, Stephan Petersenn, et al.
European Journal of Endocrinology|April 15, 2004
Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal massNicole Unger, Ingo Lopez Schmidt, Christian Pitt, et al.
European Journal of Endocrinology|December 13, 2018
MRI T2 signal intensity and tumor response in patients with GH-secreting pituitary macroadenoma: PRIMARYS post-hoc analysisFabrice Bonneville, Louis-David Rivière, Stephan Petersenn, et al.
Clinical Endocrinology|January 18, 2012
Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomasKarsten Müssig, Tobias Wehrmann, Helmut Dittmann, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 7, 2020
Bevacizumab in Aggressive Pituitary Adenomas - Experience with 3 PatientsKatharina Osterhage, Roman Rotermund, Michael Droste, et al.
European Journal of Endocrinology|October 20, 2017
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomasGerald Raverot, Pia Burman, Ann McCormack, et al.
Pageof 13